Skip to main content

Fusion Pharmaceuticals Inc.

FUSNDelisted Jun 5, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001805890

Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.

13F holders, Q4 2022

Institutional positions in Fusion Pharmaceuticals Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
30
−3 vs. Q3 2022
Shares held
28.2M
+1.65M (+6.2%) vs. Q3 2022
Total value
$88.9M
+$8.63M (+10.7%) vs. Q3 2022
New holders
3
5 more added
Sold out
6
3 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 30 institutions
Q1 2021: 38 institutionsQ2 2021: 39 institutionsQ3 2021: 40 institutionsQ4 2021: 32 institutionsQ1 2022: 28 institutionsQ2 2022: 31 institutionsQ3 2022: 34 institutionsQ4 2022: 30 institutionsQ1 2023: 38 institutionsQ2 2023: 41 institutionsQ3 2023: 41 institutionsQ4 2023: 77 institutionsQ1 2024: 114 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $88.9M
Q1 2021: $295.9MQ2 2021: $221.8MQ3 2021: $220.6MQ4 2021: $116.0MQ1 2022: $219.1MQ2 2022: $69.4MQ3 2022: $80.3MQ4 2022: $88.9MQ1 2023: $171.9MQ2 2023: $235.1MQ3 2023: $129.8MQ4 2023: $584.1MQ1 2024: $1.47BQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding FUSN and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 2024114$1.47B
Q4 202377$584.1M
Q3 202341$129.8M
Q2 202341$235.1M
Q1 202338$171.9M
Q4 202230$88.9M
Q3 202234$80.3M
Q2 202231$69.4M
Q1 202228$219.1M
Q4 202132$116.0M
Q3 202140$220.6M
Q2 202139$221.8M
Q1 202138$295.9M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q3 2022.

Institutions holding FUSN in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Johnson & Johnson3,670,516$11.6M3.36%00.0%Unchanged
OrbiMed Advisors LLC3,224,770$10.2M0.19%00.0%Unchanged
Federated Hermes, Inc.3,224,100$10.2M0.03%+50,000+1.6%Added
Canada Pension Plan Investment Board3,116,966$9.82M0.02%00.0%Unchanged
Adams Street Partners LLC2,947,809$9.29M3.10%00.0%Unchanged
FMR LLC2,692,054$8.48M0.00%−354,759−11.6%Reduced
TPG GP A, LLC2,551,794$8.04M0.16%00.0%Unchanged
Braidwell LP2,000,000$6.30M0.21%+2,000,000New
Pivotal bioVenture Partners Investment Advisor LLC1,560,984$4.92M2.14%00.0%Unchanged
Artal Group S.A.750,000$2.36M0.14%00.0%Unchanged
1832 Asset Management L.P.734,321$2.31M0.00%00.0%Unchanged
Ra Capital Management, L.P.659,992$2.08M0.04%00.0%Unchanged
Point72 Asset Management, L.P.328,868$1.04M0.00%+18,800+6.1%Added
Sio Capital Management, LLC260,448$820.4K0.44%00.0%Unchanged
Sofinnova Investments, Inc.117,099$368.9K0.02%00.0%Unchanged
Morgan Stanley107,948$340.0K0.00%+31,271+40.8%Added
UBS Group AG62,676$197.4K0.00%+7,772+14.2%Added
Sectoral Asset Management Inc57,297$180.5K0.03%00.0%Unchanged
Leonteq Securities AG53,000$166.9K0.01%+53,000New
Tekla Capital Management LLC43,394$136.7K0.01%−58,537−57.4%Reduced
Geode Capital Management, LLC25,136$79.0K0.00%00.0%Unchanged
Renaissance Technologies LLC23,500$74.0K0.00%+6,700+39.9%Added
Citadel Advisors LLC12,510$39.4K0.00%−15,984−56.1%Reduced
BlackRock Inc.8,253$26.0K0.00%00.0%Unchanged
TD Waterhouse Canada Inc.875$3.01K0.00%00.0%Unchanged
Royal Bank of Canada850$3.00K0.00%00.0%Unchanged
Truvestments Capital LLC335$1.05K0.00%00.0%Unchanged
Signaturefd, LLC300$9450.00%00.0%Unchanged
Advisor Group Holdings, Inc.30$950.00%+30New
JPMorgan Chase & Co2$00.00%00.0%Unchanged
Victory Capital Management Inc0$00.00%−50,390−100.0%Sold out
UBS Oconnor LLC0$00.00%−17,286−100.0%Sold out
Prudential Financial Inc0$00.00%−14,600−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−2,900−100.0%Sold out
Simplex Trading, LLC0$00.00%−100−100.0%Sold out
Paragon Wealth Strategies, LLC0$00.00%−30−100.0%Sold out
American Portfolios Advisors––––Not filed